Cancer BiologyCancer Research CommunicationsPeer-reviewed
ATR and PKMYT1 inhibition re-sensitize a subset of TNBC patient-derived models to carboplatin inducing mitotic catastrophe
Juliet Guay, Hellen Kuasne, Catherine Chabot…·Mark Basik
This study identifies ATR and PKMYT1 as targets to overcome carboplatin resistance in TNBC by re-sensitizing resistant models to carboplatin through mitotic catastrophe.
2 citations